Cardax, Inc. (CDXI) financial statements (2021 and earlier)

Company profile

Business Address 2800 WOODLAWN DRIVE
HONOLULU, HI 96822
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 002000
Cash and cash equivalents 002000
Receivables 000   
Inventory, net of allowances, customer advances and progress billings 1100 1
Inventory 1100 1
Prepaid expense 000000
Deposits current assets 000000
Total current assets: 223001
Noncurrent Assets
Operating lease, right-of-use asset 0
Property, plant and equipment   0000
Intangible assets, net (including goodwill) 000000
Intangible assets, net (excluding goodwill) 000000
Total noncurrent assets: 000000
TOTAL ASSETS: 223112
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 221111
Accounts payable      1
Employee-related liabilities 000000
Other undisclosed accounts payable and accrued liabilities 12111 
Debt 1     
Due to related parties 000000
Other liabilities      0
Other undisclosed current liabilities 634444
Total current liabilities: 865555
Noncurrent Liabilities
Long-term debt and lease obligation 0     
Operating lease, liability 0
Liabilities, other than long-term debt 10    
Accounts payable and accrued liabilities 00    
Due to related parties 1     
Total noncurrent liabilities: 10    
Total liabilities: 965555
Stockholders' equity
Stockholders' equity attributable to parent (7)(4)(1)(4)(4)(3)
Common stock 000000
Additional paid in capital 605856525047
Deferred compensation equity   (0)  (0)
Accumulated deficit (67)(62)(58)(56)(54)(50)
Total stockholders' equity: (7)(4)(1)(4)(4)(3)
TOTAL LIABILITIES AND EQUITY: 223112

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 12100 
Other income  00 0
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(1)(0)(0)(0)(0)
Gross profit: 01000(0)
Operating expenses (4)(5)(2)(2)(4)(17)
Other undisclosed operating income (loss)     (0)0
Operating loss: (4)(4)(2)(2)(4)(17)
Nonoperating income (expense) (1)(0)000(0)
Investment income, nonoperating  00000
Debt instrument, convertible, beneficial conversion feature 0     
Other nonoperating income    0  
Interest and debt expense (1)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes: (6)(4)(2)(2)(4)(17)
Other undisclosed income from continuing operations before income taxes 100000
Net loss available to common stockholders, basic: (5)(4)(2)(2)(4)(17)
Other undisclosed net loss available to common stockholders, diluted (0)     
Net loss available to common stockholders, diluted: (5)(4)(2)(2)(4)(17)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (5)(4)(2)(2)(4)(17)
Comprehensive loss, net of tax, attributable to parent: (5)(4)(2)(2)(4)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: